Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed)

The National Institute on Aging (NIA) offers funding for medical institutions proposing to establish or renew an Alzheimer's Disease Research Center (ADRC). The funding is provided through a Funding Opportunity Announcement (FOA) known as Alzheimer's Disease Research Centers (P30 Clinical Trial Not Allowed). The ADRCs that are supported by the NIA are spread out across different major medical institutions in the United States.

These ADRCs function as a national resource, concentrating on research related to Alzheimer's disease (AD) and related dementias (ADRD). Moreover, these centers aim to translate their research findings into improved diagnoses and care methods. They also explore ways to treat and potentially prevent AD/ADRD.

Apart from this, ADRCs work together and coordinate their research efforts with other programs as well as researchers that are funded by the National Institutes of Health (NIH). This collaboration serves to further enhance knowledge and treatment measures for AD/ADRD.